Dinara Sadykova

Prof. Dinara Sadykova


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DSDinara Sadykova
Dinara Sadykova
RРRazina Ramazanovna Рамазановна
Razina Ramazanovna Рамазановна
KSKarina Salakhova
Karina Salakhova
ESEvgeniia Slastnikova
Evgeniia Slastnikova
LGLiliya Galimova
Liliya Galimova
IVIldaria Valeeva
Ildaria Valeeva
The serotonin membrane transporter is one of the main mechanisms of plasma serotonin concentration regulation. Serotonin plays an important role in the pathogenesis of various cardiovascular diseases, stimulating the proliferation of smooth muscle cells, key cells in the process of hypertrophic vascular remodeling. Vascular remodeling is one of the leading prognostically unfavorable factors of atherosclerosis, the main manifestation of familial hypercholesterolemia. Familial hypercholesterolemia is one of the most common genetically determined lipid metabolism disorders and occurs in 1 in 313 people. The aim of our study was to investigate the levels of plasma and platelet serotonin, 5-hydroxyindoleacetic acid, and membrane transporter in a cross-sectional study of two pediatric groups, including patients with familial hypercholesterolemia and the control group, which consisted of apparently healthy children without cardiovascular diseases. The study involved 116 children aged 5 to 17 years old. The proportion of boys was 50% (58/116) and the average age of the children was 10.5 years (CI 2.8–18.1). The concentrations of serotonin in blood plasma and platelets and 5-hydroxyindoleacetic acid were higher in children with familial hypercholesterolemia than in the controls. The concentration of the serotonin transporter in platelets in healthy children, compared with the main group, was 1.3 times higher. A positive correlation was revealed between the level of serotonin (5-HT and PWV: ρ = 0.6, p < 0.001), its transporter (SERT and PWV: ρ = 0.5, p < 0.001), and the main indicators of arterial vascular stiffness. Our study revealed the relationship between high serotonin and SERT concentrations and markers of arterial stiffness. The results we obtained suggest the involvement of serotonin and SERT in the process of vascular remodeling in familial hypercholesterolemia in children.

Verified
Journal Article
Open access
PDF file
DSDinara Sadykova
Dinara Sadykova
RРRazina Ramazanovna Рамазановна
Razina Ramazanovna Рамазановна
KSKarina Salakhova
Karina Salakhova
ESEvgeniia Slastnikova
Evgeniia Slastnikova
LGLiliya Galimova
Liliya Galimova
ДЦДмитрий Цыплаков
Дмитрий Цыплаков
Familial hypercholesterolemia leads to the early development of cardiovascular diseases at a young age due to the prolonged exposure of the arterial vessel wall to high concentrations of atherogenic lipids. Serotonin plays a significant role in the development and progression of atherosclerotic processes. Monoamine has a damaging effect on the vascular wall, stimulates the proliferation of vascular smooth muscle cells and fibroblasts, and participates in platelet activation and aggregation. The aim of the work was the demonstration of the importance of serotonin, transporters, and receptors in the pathogenesis of atherosclerotic plaque formation. The study was performed on immature mice of the C57BL/6JGpt-Ldlrem1Cd82/Gpt (Ldlr+/−) line (main group) and C57BL/6 mice of comparable age and sex demographics (control group). Morphological manifestations of early signs of atherosclerosis (pre-lipid stage and lipoidosis stage, which were confirmed by Sudan III staining) in the gene-modified mice’s aorta were determined. Morphological changes in the aorta correlated with changes in the left ventricle of the heart, where lipid content also increased. No atherosclerotic changes in the control-group mice were detected. A statistically significant increase in the expression of the membrane serotonin transporter and 5HT2A and 5HT2B receptors in both the aorta and left ventricle was also found in the animals of the main group. Serotonin and its receptors and transporter may become new therapeutic targets for the treatment and prevention of atherosclerotic vascular lesion progression in children and adults.

23 May 2023 in Children
Verified
Journal Article
Open access
PDF file
NGN. Kh. Gabitova
N. Kh. Gabitova
ICI. N. Cherezova
I. N. Cherezova
Ahmed ArafatAhmed Arafat
Ahmed Arafat
DSDinara Sadykova
Dinara Sadykova
Background: Interstitial lung disease (ILD) is one of the most difficult conditions in pulmonology due to difficulties in diagnosing, classifying, and treating this condition. They require invasive approaches to diagnose (e.g., lung biopsy), non-applicable methods (e.g., lung function tests in newborns), or potentially non-accessible methods (e.g., genetic testing in not-well-equipped facilities, and several weeks are required for results to be announced). They represent a heterogeneous group of diseases in which the alveolar epithelium, parenchyma, and capillaries of the lungs are damaged, which leads to changes in the pulmonary interstitium, proliferation of connective tissue, and thickening of the alveolar-capillary membranes and alveolar septa. These changes are accompanied by impaired oxygen diffusion, progressive respiratory failure, and radiographic signs of bilateral dissemination. Although adult and child classifications for ILD have evolved over the years, classification for ILD in neonates remains a challenge. Case presentation: Here we discuss ILD in neonates briefly, and report two rare cases of ILD (a male white neonate, two-day-old with fibrosing alveolitis, and another male white neonate, one-day old with desquamative interstitial pneumonitis), with these diagnoses initially thought to be presented only in adulthood. Lung biopsy and histopathological findings of the two neonates have shown mononuclear cells in the alveolar spaces, and thickening of the alveolar walls confirmed the diagnosis of fibrosing alveolitis in one neonate, and desquamation of the large mononuclear cells in the intra-alveolar space in the other neonate, with the diagnosis of desquamative interstitial pneumonitis being confirmed. Interstitial lung disease lacks a consensus guideline on classification and diagnosis in neonates, rendering it one of the greatest challenges to pediatricians and neonatologists with remarkable morbidity and mortality rates. Conclusions: Fibrosing alveolitis and desquamative interstitial pneumonitis (DIP) are not adult-only conditions, although rare in neonates, histopathological examination and clinical practice can confirm the diagnosis. Based on our clinical practice, prenatal and maternal conditions may serve as potential risk factors for developing IDL in neonates, and further studies are needed to prove this hypothesis.

21 July 2021
Verified
Book Chapter
Open access
PDF file
DSDinara Sadykova
Dinara Sadykova
LGLiliia Galimova
Liliia Galimova
ESEvgeniia Slastnikova
Evgeniia Slastnikova
ZKZulfiia Khabibrakhmanova
Zulfiia Khabibrakhmanova
NGNatalya Guseva
Natalya Guseva
Familial hypercholesterolemia (FH) is the most common genetic disorder in the world. It is characterized by increased level of total cholesterol (TC), low-density lipoproteins (LDL-C) since childhood. The diagnosis and initiation of therapy are optimal in childhood before complications (aortic stenosis, atherosclerotic changes in the arterial walls) appear. The initiation of lipid-lowering therapy in FH since childhood is important to reduce the cumulative effect of LDL-C, to increase patient’s life expectancy. Statins are recommended as first-line drugs for treatment with monitoring of the recommended clinical, biochemical markers under the supervision of a physician. However, due to limited experience, there are differing opinions among clinicians regarding the age of initiation of lipid-lowering therapy. This review is an attempt to critically study the available data from the world literature concerning the use of statins in children with FH, their effectiveness, safety. It is important to determine the endpoints for determining the effectiveness of statins, such as lowering LDL-C, assessing the thickness of the intima-media complex. The frequency of occurrence of possible side effects in children is considered - diabetes mellitus, hepatotoxicity, muscle pain and others. There is a need to continue randomized trials to prove the lifelong benefit of low LDL-C in patients with FH.

20 November 2018 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
DSDinara Sadykova
Dinara Sadykova
RKR. Sh. Khasanov
R. Sh. Khasanov
NYN. Z. Yusupova
N. Z. Yusupova
MBM. V. Belousova
M. V. Belousova
ТMТ. V. Mikhaylova
Т. V. Mikhaylova
ЮМЮ. В. Марянина
Ю. В. Марянина
The article describes the experience of implementing the “Emergency pediatrics” educational program with the use of simulation training methods, mobile simulation equipment, and distance educational technologies. The program is aimed at improving the doctors’ professional competence in emergency medical care for children. This format of the training helps to train the largest number of doctors in accordance with the international standards for emergency medical care on-the-job. The educational program makes it possible to assess the level of initial and final knowledge, to monitor professional skills, to determine the degree of the doctor’s readiness for emergency medical care for children. Based on the results of the incoming test control and assessment of basic cardiopulmonary resuscitation skills, we can conclude that the pediatricians have insufficient theoretical and practical skills of emergency care. As a promising direction, we plan to create a Register for sudden cardiac arrest, the Register of survival after sudden cardiac arrest in children at hospital and outside the hospital, which improve the quality of emergency and urgent care for children.

11 February 2020 in Kazan medical journal
Verified
Journal Article
Open access
PDF file
DSDinara Sadykova
Dinara Sadykova
NSN A Solov’ev
N A Solov’ev
GKG A Kulakova
G A Kulakova
EKE A Kurmayeva
E A Kurmayeva
СИСадыкова Динара Ильгизаровна
Садыкова Динара Ильгизаровна
КАКурмаева Елена Анатольевна
Курмаева Елена Анатольевна
Aim. To analyze the medical and social characteristics of children's disability at the stage of primary medical and social care in the polyclinics of Kazan. Methods. 185 case reports of development of children with disabilities aged 0 to 17 years were analyzed as well as the questionnaires for their parents and 96 case reports of healthy peers of the same age group based on the data from children polyclinics N. 9 and 7 of Kazan. Relative values were calculated to process the results. Results. The conducted analysis revealed that children with the status of disabled persons were more often born in aged and young mothers, with pathological pregnancy and first birth. In the structure of disability causes, psychiatric disorders and nervous system diseases are prevailing. Disabled children acquire acute diseases more often than their healthy peers that causes additional expanses for the family, including those due to the care for acutely ill child, and requires additional provision with medications. Individual lessons in the rehabilitation of a child with disabilities require additional financial investments from the family budget. We revealed the need for implementation of educational courses for the parents of disabled children due to that every second family did not have specific knowledge and skills of care and rehabilitation, when a child had functional limitations found. Conclusion. Families with children with disabilities in the status of a disabled child need additional assistance in solving medical and social problems.